Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | PSMB9 |
Upstream (Parents) |
---|
(<<) CXCL10 → PSMB9 |
(<<) DDX60 → PSMB9 |
(<<) BTN3A3 → PSMB9 |
(<<) HLA-DMA → PSMB9 |
(<<) UBE2L6 → PSMB9 |
(<<) TAP1 → PSMB9 |
(<<) HLA-F → PSMB9 |
(<<) HLA-C → PSMB9 |
Downstream (Children) |
---|
PSMB9 → DLX2 (>>) |
PSMB9 → POU6F2 (>>) |
PSMB9 → UBD///GABBR1 (>>) |
PSMB9 → AIM2 (>>) |
PSMB9 → CXCR3 (>>) |
PSMB9 → CASP1 (>>) |
PSMB9 → IL15 (>>) |
PSMB9 → HCP5 (>>) |
PSMB9 → HCG26 (>>) |
PSMB9 → MYL7 (>>) |
PSMB9 → SECTM1 (>>) |
PSMB9 → TAP1 (>>) |
PSMB9 → HLA-F (>>) |
PSMB9 → HLA-C (>>) |